They Called the Evidence "Limited." It Is Grade A. What the Data Actually Says About Testosterone, Desire, and Your Orgasm After 50

There are two words that travel faster through a doctor's office than almost any others, and they can undo a woman in a single sentence. Limited evidence. A new paper uses them about testosterone and orgasm, and I need you to understand exactly how wrong that framing is, because the difference between wrong and right here is the difference between a woman getting help and a woman going home to blame herself.

Let me start where every honest argument starts. With the data.

In 2019, a team at Monash University led by Rakibul Islam and Susan Davis published a systematic review and meta analysis in the Lancet Diabetes and Endocrinology. They gathered thirty six randomized controlled trials, 8,480 women, and pooled the results. This is not a single small study with a hopeful conclusion. This is the entire body of evidence weighed at once. Compared to placebo, testosterone significantly improved sexual desire, arousal, orgasm, pleasure, responsiveness, and self image, and it reduced sexual distress. Every domain that matters, moving in the right direction, across thousands of women.

Go back further, to the year 2000, and Jan Shifren's trial in the New England Journal of Medicine. Women who had lost their ovarian testosterone to surgery started with sexual function scores at fifty two percent of the normative range. On the higher dose of testosterone, those scores rose to eighty one percent. I will tell you the whole truth, which is more than the dismissers do. The placebo group also rose, to seventy two percent. The testosterone group went significantly further, and the domains that gained the most were sexual activity and pleasure and orgasm. Including the placebo number does not weaken the case. It is what makes the case unassailable.

Then 2008, the New England Journal again, this time led by Susan Davis. Eight hundred and fourteen women. The testosterone patch roughly tripled the increase in satisfying sexual events compared to placebo, with real gains in desire, arousal, orgasm, and pleasure. The authors described the absolute increase as modest. Good researchers say modest when they mean modest. Hold that word, because it is about to matter enormously.

In 2019 the leading menopause and sexual medicine societies in the world issued the Global Consensus Position Statement on testosterone therapy for women. Ten international bodies. They graded the evidence for testosterone improving sexual function in postmenopausal women with low desire as Level One, Grade A. There is no higher grade in medicine. It is the same tier of evidence we use to justify treatments no one questions.

So where did limited evidence come from.

Here is the sleight of hand, and once you see it you cannot unsee it. In the United States, there is no testosterone product approved by the FDA for women. That is true. Using it means a male formulation prescribed off label or a compounded preparation. Also true. These are regulatory facts. But watch the swap. Off label quietly becomes limited evidence. Not FDA approved quietly becomes unproven. And those swaps are dishonest, because the shelf is empty for a business reason, not a scientific one. No company took a small market through a long, costly approval process. That is a market failure. It says nothing about whether the hormone works inside your body. The evidence is Grade A. The pharmacy shelf is bare. Those are two different sentences, and blurring them sends women home believing their desire is a personal defect instead of an underserved market.

Notice also the difference between modest and limited. The 2008 authors said modest, meaning the effect is real and measurable and not enormous. Limited implies the science is thin or unreliable. It is not. It is Grade A. A modest, honestly reported, top tier finding is exactly what good medicine looks like. Collapsing that into limited evidence is not a summary. It is a dismissal. And every time it gets printed, a clinician gets permission to stop listening to a patient.

Now let me tell you the part I would never leave out, because it is my whole life's work. Testosterone is real, and it is not the entire story.

Testosterone feeds the brain system the neuroscientist Jaak Panksepp named SEEKING, the dopamine driven engine of wanting and anticipation itself. Research in Nature Neuroscience in 2025 mapped how ovarian hormone signaling and dopamine communicate in the circuits that drive motivation. Cindy Meston's decades of work show that female arousal is physiological as much as psychological, running on blood flow and sensation and readiness of tissue. So the data has a mechanism underneath it. This is not placebo.

And yet. You can have perfect hormones and still feel nothing. Because arousal requires your nervous system to come out of protection mode first. Peter Levine's work shows how a body holds old threat long after it has passed. Research on interoception by Sarah Garfinkel and Hugo Critchley shows that whether you can even sense what is happening inside your body depends on how safe your system feels. Lori Brotto has run the trials proving that training attention back into the body improves desire and arousal on its own.

So here is the full picture that medicine almost never offers you. Testosterone sets the stage. Your nervous system decides whether the show goes on. If you are still living in caregiving and hypervigilance and the low hum of never being off duty, your body will keep the pleasure door closed no matter what is circulating in your blood. This is not a libido problem. It is a capacity problem. Medicine dismissed the hormone and never even knocked on the nervous system. Two closed doors. You were told the science did not exist behind either one.

It exists. You are not broken. Your desire did not leave. It went underground, waiting for safety, and something underground can come back up.

I wrote the whole roadmap for this in my book, Are We Gonna Have Sex or What. It walks you through the science, the somatic practices, and the phases of coming back to yourself. Get your copy at juliemerrimanphd.com. And the full breakdown of every trial, every number, and every receipt from this episode is live on my Instagram today. Go read it, and then send it to the friend who was told her body was the problem.